usa

When people discuss modern medicine, accuracy plays one of the most important roles and human lives are directly dependent on it. Hereby, any researches pertaining to medicine are necessary to meet the top standards. The problem nowadays is that any results of researches can be published online and used as a reference without being thoroughly verified and validated. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this problem and decided to create an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been established back in 2010. The key principle of this journal is based on Altmetric scores that are used as a quality measure. That helps both readers and authors to validate publications with Altmetric Article Reports that create “real-time feedback containing data summary related to a particular publication. ” Oncotarget website provides a full publications list with corresponding scores above 100 as well as reports di...

Scientists discuss their findings in a recently published paper in Oncotarget entitled, “ONC201 kills breast cancer cells in vitro by targeting mitochondria.” Oncotarget’s Behind The Study v1 The Behind the Study series transcribes videos of chosen researchers elaborating on their recent papers published in Oncotarget. Visit the Oncotarget YouTube channel for more insights from outstanding authors. Oncotarget Stan Lipkowitz Hello, I’m Stan Lipkowitz, the Branch Chief of the Women’s Malignancies Branch at the National Cancer Institute. Yoshimi Greer Hi, I’m Yoshimi Greer, Staff Scientist in Women’s Malignancies Branch, National Cancer Institute, NIH, Bethesda, Maryland. I’m the first author of the paper. Stan Lipkowitz So today we’d like to talk about our work with a novel class of drugs first described as a drug called ONC201 and a paper we published (in Oncotarget) on that demonstrating a novel mechanism of action, whereby the drugs target the mitochondria to kill bre...

When public speak of contemporary medicine, precision plays one of the most important roles and human lives are directly dependent on it. Hence, any researches pertaining to medicine are necessary to comply with the top standards. The challenge nowadays is that any outcomes of researches can be posted online and used as a reference without being thoroughly checked and approved. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this issue and decided to develop an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been founded back in 2010. The key principle of this journal is related to Altmetric scores that are used as a quality measure. That helps both readers and authors to validate publications with Altmetric Article Reports that create “real-time feedback containing data summary related to a particular publication. ” Oncotarget website has a complete publications list with respective scores higher than 100 as well as...

When general population discuss modern medicine, precision plays one of the most important roles and human lives are literally dependent on it. Hence, any researches related to medicine are necessary to comply with the top standards. The problem nowadays is that any recommendations of researches can be published online and used as a reference without being thoroughly checked and approved. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this issue and attempted to develop an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been established back in 2010. The key principle of this journal is based on Altmetric scores that are used as a quality measure. That assists both readers and authors to verify publications with Altmetric Article Reports that generate “real-time feedback containing data summary related to a particular publication. ” Oncotarget website has a complete publications list with corresponding scores higher...

Now more than ever, the general public is witnessing the significance of medical research. The coronavirus pandemic has disrupted all our lives and will continue to do so until a vaccine is developed and distributed on a massive scale. This vaccine, once it finally arrives, will be the product of extensive development and testing. These efforts – whether it be for a virus vaccine or to combat cancer – cannot proceed without financial backing. Ride for Roswell acknowledges the importance of fiscal support. Rather than postpone its 2020 event, which is also its 25th consecutive year, organizers buckled down and found a work-around. “Summer of the Ride” is this year’s alternative and offers safe group rides as well as ride-from-home measures to encourage participation and donations. All told, Ride for Roswell has raised more than $55 million toward cancer research throughout its two-decade-plus run. Mikhail Blagosklonny, of peer-reviewed medical journal Oncotarget, is proud to be a part ...

When people refer to contemporary medicine, precision plays one of the most important roles and human lives are directly dependent on it. Hence, any researches related to medicine are required to meet the highest standards. The problem today is that any results of researches can be published online and used as a reference without being thoroughly verified and validated. Mikhail (Misha) Blagosklonny of Oncotarget clearly understood this challenge and tried to generate an alternative solution. That’s how a weekly oncology-focused research journal called “Oncotarget” has been founded back in 2010. The main principle of this journal is based on Altmetric scores that are used as a quality measure. That allows both readers and authors to verify publications with Altmetric Article Reports that create “real-time feedback containing data summary related to a particular publication. ” Oncotarget website provides a complete publications list with corresponding scores above 100 as well as repor...

A recent study discovers new potential target mechanisms for leukemia treatments found in a novel study of down syndrome endothelial cells. Researcher at microscope The Trending with Impact series highlights publications attracting higher visibility among readers around the world online, in the news, and on social media beyond normal readership levels. Look for future science news and articles about the latest trending publications here. — Researchers from the Northwestern University Feinberg School of Medicine, Stanley Manne Children’s Research Institute, the Russian Academy of Sciences, and ARTEC Biotech Inc. were encouraged to learn more about the mechanisms involved in the increased risk of leukemia for people with down syndrome and how they also correlate with lower tumor expression. Previous studies have found that people with down syndrome present with a unique cancer profile. Their genetic material makes them vulnerable to certain cancers, such as leukemia, however, they al...